跳至主要内容
临床试验/NCT01756144
NCT01756144Unknown不适用

rhBMP-2 vs Autologous Bone Grafting for the Treatment of Non-union of the Docking Site in Tibial Bone Transport

Universitaire Ziekenhuizen KU Leuven0 个研究点目标入组 20 人开始时间: 2015年7月最近更新:
适应症

试验速览

阶段
不适用
入组人数
20
主要终点
Bone healing in the docking site

研究概览

简要总结

When there is a bone defect, bone transport is used to bridge the defect. Frequently, the bone in the docking site (where the transported bone comes together) doesn't heal.

The objective is to study the effectivity of rhBmp-2 (inductos) to stimulate bone healing, in order to find new techniques to treat non-union of long bones.

The method of the study is a randomized controlled trial, to compare rhBMP-2 and autologous bone grafting in stimulating bone healing in the docking site.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients treated with bone transport (Ilizarov technique) and have non-union of the docking site, which is characterized by absence of bridging callus after two months of compression in the docking site.

排除标准

  • Allergy for inductos
  • active growth,
  • malignancy
  • infection
  • pathological fracture

结局指标

主要结局

Bone healing in the docking site

时间窗: up to 4 months

次要结局

  • Infection(up to one year)
  • Edema(up to one year)
  • cancer(up to one year)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Dr Jan Vanderstappen

MD

Universitaire Ziekenhuizen KU Leuven

相似试验